Dosidal · Switzerland
REVLIMID, Hartkapseln
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:57712 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 57712 atc: L04AX04 |
| Source authority | Swissmedic |
| Read date | |
| authorisation status | first_authorisation: 2007-08-29 term: zugelassen valid_until: 9999-12-31 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: L04AX04 authorisation_number: 57712 form: KAHA holder: Bristol-Myers Squibb SA holder_partner_nr: 1100488 it_number: 07.16.4. name: REVLIMID, Hartkapseln state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53eMdJR_UguVPaC3SG-Y0qHeOnwdhU8uP9G3Rg6KHDAoHRGrfexp5Uujr4QIc0En4dTFffp__GCcinp-8108Y4QwVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/ch:authorisation:57712 · Same medicine in other markets · Dosidal